2015
Patterns of response and relapse of primary central nervous system lymphomas (PCNSL) following first line of high-dose methotrexate-based chemotherapy (hdMTX): Analysis of a prospective ANOCEF randomized phase II trial.
Tabouret E, Houillier C, Martin-Duverneuil N, Blonski M, Soussain C, Ghesquieres H, Houot R, Delwail V, Soubeyran P, Gressin R, Gyan E, Chinot O, Taillandier L, Tanguy M, Omuro A, Hoang-Xuan K. Patterns of response and relapse of primary central nervous system lymphomas (PCNSL) following first line of high-dose methotrexate-based chemotherapy (hdMTX): Analysis of a prospective ANOCEF randomized phase II trial. Journal Of Clinical Oncology 2015, 33: 2035-2035. DOI: 10.1200/jco.2015.33.15_suppl.2035.Peer-Reviewed Original Research
2012
Primary Central Nervous System Lymphomas
Graber J, Omuro A. Primary Central Nervous System Lymphomas. 2012, 125-133. DOI: 10.1002/9781118321478.ch12.Peer-Reviewed Original ResearchPrimary CNS lymphomaHigh-dose methotrexate-based chemotherapyPrimary central nervous system lymphomaCentral nervous system lymphomaMethotrexate-based chemotherapyNervous system lymphomaNon-Hodgkin lymphomaLong-term survivalCNS lymphomaOptimal regimenImmunosuppressed patientsSystem lymphomaAppropriate therapyDisease relapseEarly suspicionDiagnostic accuracyLymphomaInappropriate interventionsPatientsImmunocompetentRegimenChemotherapyRelapseRadiotherapyNeurotoxicity